Skip to main content
. 2012 Jul 17;7:16. doi: 10.1186/1750-9378-7-16

Table 1.

Detection of galectin-9 in biopsies from head and neck carcinomas

Patient
Origin
Gender/Age
Tumor site/Histological Type
Clinical stage
Galectin-9 staining
 
 
 
 
 
Malignant cells
Stroma cells
Adjacent mucosa
              (epithelium type)
1
Tunisia
M/48
NPC/UNK*
T4N3bM1
+ +
+
- (malpighian)
2
Romania
F/34
NPC/UNK
T2bN0M0
+ +
+
- (malpighian)
3
Cameroon
M/62
NPC/UNK
T4N2M0
+ +
-
+ (secretory)
4
France
M/63
NPC/UNK
T4N0Mx
+ +
+
n/a
5
France
M/62
NPC/UNK
T3N2M0
+ +
+
n/a
6
Portugal
F/84
NPC/UNK
T4N2M0
+ +
+
n/a
7
Algeria
M/40
NPC/UNK
T4N2M0
+ +
-
+ (malpighian)
8
Turkey
M/57
NPC/UNK
T1N0M0
+ +
+
n/a
9
China
F/31
NPC/UNK
T4N0M0
+ +
-
- (malpighian)
10
France
M/48
NPC/UNK
T1N2M0
+ +
-
- (secretory)
11
France
M/62
Tonsil/Infiltrating SCC**
T2N1M0
+
+
- (malpighian)
12
France
F/82
Tongue/Differentiated SCC
T2N0M0
-
+
- (malpighian)
13 France M/64 Pelvi-lingual furrow/Differentiated SCC T2N1M0 - + - (malpighian)

* NPC/UNK : nasopharyngeal carcinoma/undifferentiated non-keratinizing, ** SCC : squamous cell carcinoma, ++ : intense and homogeneous galectin-9 staining, + : moderate or scattered galectin-9 staining, - : absence of galectin-9 staining, n/a : not applicable (no segment of non malignant mucosa observed in the tissue section).